Eliem Therapeutics Price to Book Ratio 2021-2024 | CLYM
Historical price to book ratio values for Eliem Therapeutics (CLYM) over the last 10 years. The current price to book ratio for Eliem Therapeutics as of October 04, 2024 is 1.53.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Eliem Therapeutics Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-10-03 |
5.10 |
|
1.33 |
| 2024-03-31 |
2.74 |
$3.84 |
0.71 |
| 2023-12-31 |
2.70 |
$3.88 |
0.70 |
| 2023-09-30 |
2.63 |
$4.00 |
0.66 |
| 2023-06-30 |
2.80 |
$4.17 |
0.67 |
| 2023-03-31 |
2.90 |
$4.33 |
0.67 |
| 2022-12-31 |
3.67 |
$4.84 |
0.76 |
| 2024-06-30 |
7.11 |
$3.33 |
2.14 |
| 2022-09-30 |
3.23 |
$5.06 |
0.64 |
| 2022-06-30 |
3.02 |
$5.35 |
0.56 |
| 2022-03-31 |
8.39 |
$5.84 |
1.44 |
| 2021-12-31 |
10.46 |
$6.29 |
1.66 |
| 2021-09-30 |
17.98 |
$6.74 |
2.67 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.342B |
$0.000B |
|
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|
